TRUS and biopsy: Practical aspects

European Urology

Volumn 41, Issue 6, 2002, Pages 1-10

  Hendrikx, A ^a   Safarik, L ^b   Hammerer, P ^c  

^a CATHARINA HOSPITAL   (Netherlands)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER ASSISTED DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMAGE ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); PALPATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0036624906     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00044-1     Document Type: Article

References (40)

1. Seidman H, Mushinski MH, Gelb SK, Silverberg E. Probabilities of eventually developing or dying of cancer - United States 1985. CA Cancer J Clin 1985; 35:36-56.
2. Feneley MR, Partin AW. Diagnosis of localized prostate cancer: 10 years of progress. Curr Opin Urol 2000; 10:319-27.
3. Rifkin MD, Kurtz AB, Choi HY, Goldberg BB. Endoscopic ultrasonic evaluation of the prostate using a transrectal probe: Prospective evaluation and acoustic characterisation. Radiology 1983;149:265-71.
4. Lee F, Torp-Pederson ST, Siders DB, Littrup PJ, McLeary RD. Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. Radiology 1989;170:609-15.
5. Sedelaar JP, Vijverberg PL, De Reijke TM, de la Rosette JJ, Kil PJ, Braeckman JG, Hendrikx AJ. Transrectal ultrasound in diagnosis of prostate cancer: State of the art and perspectives. Eur Urol 2001;40:275-84.
6. Levine MA, Ittman M, Melamed J, Lepor H. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 1998;159:471-6.
7. Svetec D, McCabe K, Peretsman S, Klein E, Levin H, Optenberg S, et al. Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer. J Urol 1998;159:1606-8.
8. Aarnink RG, Beerlage HP, de la Rosette J, Debruyne FM, Wijkstra H. Transrectal ultrasound of the prostate: Innovations and future applications. J Urol 1998;159:1568-79.
9. Ronco AL, Fernandez R. Improving ultrasonographic diagnosis of prostate cancer with neural networks. Ultrasound Med Biol 1999;25:729-33.
10. Loch T, Leuschner I, Genberg C, Weichert-Jacobsen K, Kuppers F, Yfantis E, et al. Artificial neural network analysis (ANNA) of prostatic transrectal ultrasound. Prostate 1999;39:198-204.
11. Borre M, Offersen BV, Nerstrom B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998;78:940-4.
12. Folkman J, Cotran R. Relation of vascular proliferation to tumour growth. Int Rev Exp Pathol 1976;16:207-48.
13. Rifkin D, Sudakoff GS, Alexander AA. Prostate: Techniques, results and potential applications of color Doppler US scanning. Radiology 1993;168:509-13.
14. Hendrikx AJM, Klomp M, Keyzer J, Arends B, Zonneveld G. The role of colour velocity imaging (CVI) in prostate ultrasound. Eur J Ultrasound 1996; 3:15-23.
15. Cornud F, Belin X, Piron D, Chretien Y, Flam T, Casanova JM, et al. Color Doppler-guided prostate biopsies in 591 patients with an elevated serum PSA level: Impact of Gleason score for nonpalpable lesions. Urology 1997;49:709-15.
16. Kelly IMG, Lees WR, Rickards D. Prostate cancer and the role of colour Doppler ultrasonography. Radiology 1993;189:153-6.
17. Sakarya ME, Arsian H, Unal O, Atilla MK, Aydin S. The role of power Doppler ultrasonography in the diagnosis of prostate cancer: A preliminary study. Br J Urol 1998;82:386-8.
18. Cho JY, Kim SH, Lee SE. Peripheral hypoechoic lesions of the prostate: Evaluation with colour and power Doppler ultrasound. Eur Urol 2000;37:443-8.
19. Bogers JA, Sedelaar JPM, Beerlage HP, de la Rosette J, Debruyne F, Wijkstra A, et al. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: Correlation with biopsy outcome. Urology 1999;54:97-104.
20. Terris et al. Estimation of prostate cancer volume by transrectal ultrasound imaging. J Urol 1992;147:855-7.
21. Rietbergen JB, Kranse R, Hoedemaeker RF, Kruger AE, Bangma CH, Kirkels WJ, et al. Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study. Urology 1998;52:237-46.
22. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-6.
23. Babaian RJ, Toi A, Kamoi K, Troncoso P, Sweet J, Evans R, et al. A comparative analysis of sextant and extended 1-core multisite directed biopsy strategy. J Urol 2000;163:152-7.
24. Presti Jr JC, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include eight rather than six biopsies: Results of a prospective clinical trial. J Urol 2000;163:163-7.
25. Lui PD, Terris MK, McNeal JE, Stamey TA. 1995 Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J Urol 1995;153:1000-3.
26. Matzkin H, Patel JP, Altwein JE, Soloway MS. Stage T1A carcinoma of the prostate. Urology 1994;43:11-21.
27. Borboroglu PG, Comer SW, Rifenburgh RH, Amling ChL. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000;163:158-62.
28. Djavan B, Zlotta A, Remzi M, Ghawindel K, Basharkhah A, Schulman CC, et al. Optimal predictors of prostate cancer on repeat prostate biopsy: A prospective study of 1051 men. J Urol 2000;163:1144-9.
29. Schroeder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R. Prostate cancer detection at low prostate specific antigen. J Urol 2000;163:806-12.
30. Catalona WJ, Ramos CG, Carvalhal GF, Yan Y. Lowering PSA cutoffs to enhance detection of curable prostate cancer. Urology 2000;55:791-5.
31. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281:1591-7.
32. Weinstein MH, Epstein JI. Significance of high grade prostatic significance of high grade prostatic intraepithelial neoplasia (PIN) on needle biopsy. Hum Pathol 1993;24:624-9.
33. McNeal JE. The zonal anatomy of the prostate. Prostate 1981;2:35-240.
34. Lee F, Torpedersen S, Littrup PJ, McLeary RD, McHugh TA. Hypoechoic lesions of the prostate: Clinical relevance of tumor size, digital rectal examination, and prostate-specific antigen. Radiology 1989;170:29-32.
35. Isen K, Kupeli B, Sinik Z, Sozen S, Bozkirii I. Antibiotic prophylaxis for transrectal biopsy of the prostate: A prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol 1999;31:491-5.
36. Sieber PR, Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Harpster LE. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 1997;157:2199-200.
37. Aus G, Ahigren G, Bergdahl S, Hugosson J. Infection after transrectal core biopsies of the prostate-risk factors and antibiotic prophylaxis. Br J Urol 1996;77: 851-5.
38. Naughton CK, Miller DC, Yan Y. Impact of transrectal ultrasound guided prostate biopsy on quality of life: A prospective randomized trial comparing 6 versus 12 cores. J Urol 2001;165:100-3.
39. Issa MM, Bux S, Chun T, Petros JA, Labadia AJ, Anastasia K, et al. A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy: The Emory University experience. J Urol 2000;164:397-9.
40. Moul JW, Miles BJ, Skoog SJ, McLeod DG. Risk factors for perineal seeding of prostate cancer after needle biopsy. J Urol 1989;142:86-8.